Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 171

1.

Prognostic clinical factors in patients affected by non-small-cell lung cancer receiving Nivolumab.

Pantano F, Russano M, Berruti A, Mansueto G, Migliorino MR, Adamo V, Aprile G, Gelibter A, Ficorella C, Falcone A, Russo A, Aieta M, Maio M, Martelli O, Barni S, Napolitano A, Roca E, Quadrini S, Iacono D, Russo A, Calvetti L, Occhipinti MA, Cortellini A, Vasile E, Passiglia F, Imperatori M, Calabrò L, Di Giacomo AM, Petrelli F, Pasquini G, Franchina T, Venditti O, Intagliata S, Galvano A, Fioroni I, Vincenzi B, Tonini G, Santini D.

Expert Opin Biol Ther. 2020 Feb 6:1-8. doi: 10.1080/14712598.2020.1724953. [Epub ahead of print]

PMID:
32011207
2.

Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Outcomes with Nivolumab in Pretreated Non-Small Cell Lung Cancer (NSCLC): A Large Retrospective Multicenter Study.

Russo A, Russano M, Franchina T, Migliorino MR, Aprile G, Mansueto G, Berruti A, Falcone A, Aieta M, Gelibter A, Russo A, Barni S, Maio M, Martelli O, Pantano F, Iacono D, Calvetti L, Quadrini S, Roca E, Vasile E, Imperatori M, Occhipinti M, Galvano A, Petrelli F, Calabrò L, Pasquini G, Intagliata S, Ricciardi GRR, Tonini G, Santini D, Adamo V.

Adv Ther. 2020 Jan 30. doi: 10.1007/s12325-020-01229-w. [Epub ahead of print]

PMID:
32002809
3.

Hema-Functionalized Graphene Oxide: a Versatile Nanofiller for Poly(Propylene Fumarate)-Based Hybrid Materials.

Vasile E, Pandele AM, Andronescu C, Selaru A, Dinescu S, Costache M, Hanganu A, Raicopol MD, Teodorescu M.

Sci Rep. 2019 Dec 10;9(1):18685. doi: 10.1038/s41598-019-55081-2.

4.

Pancreatic resections for metastases: A twenty-year experience from a tertiary care center.

Di Franco G, Gianardi D, Palmeri M, Furbetta N, Guadagni S, Bianchini M, Bonari F, Sbrana A, Vasile E, Pollina LE, Mosca F, Di Candio G, Morelli L.

Eur J Surg Oncol. 2019 Nov 28. pii: S0748-7983(19)31465-9. doi: 10.1016/j.ejso.2019.11.514. [Epub ahead of print]

PMID:
31806518
5.

Corrigendum to "Gastric cancer: Translating novels concepts into clinical practice" [Cancer Treatm. Rev. 79C (2019) 101889].

Salati M, Orsi G, Smyth E, Aprile G, Beretta G, De Vita F, Di Bartolomeo M, Fanotto V, Lonardi S, Morano F, Pietrantonio F, Pinto C, Rimassa L, Vasile E, Vivaldi C, Zaniboni A, Ziranu P, Cascinu S.

Cancer Treat Rev. 2019 Dec;81:101932. doi: 10.1016/j.ctrv.2019.101932. Epub 2019 Nov 23. No abstract available.

PMID:
31771795
6.

Structure-grain size-synthesis route of silver nanoparticles: a correlation with the cytotoxic effect.

Vasile OR, Andronescu E, Truşcă R, Vasile E, Holban AM, Chifiriuc MC, Iordache F, Maniu H, Bleotu C, Neacşu IA, Vasile BŞ.

Rom J Morphol Embryol. 2019;60(2):617-628.

7.

Validated Nomogram Predicting 6-Month Survival in Pancreatic Cancer Patients Receiving First-Line 5-Fluorouracil, Oxaliplatin, and Irinotecan.

Fornaro L, Leone F, Vienot A, Casadei-Gardini A, Vivaldi C, Lièvre A, Lombardi P, De Luca E, Vernerey D, Sperti E, Musettini G, Satolli MA, Edeline J, Spadi R, Neuzillet C, Falcone A, Pasquini G, Clerico M, Passardi A, Buscaglia P, Meurisse A, Aglietta M, Brac C, Vasile E, Montagnani F.

Clin Colorectal Cancer. 2019 Dec;18(4):e394-e401. doi: 10.1016/j.clcc.2019.08.004. Epub 2019 Sep 4.

PMID:
31564556
8.

Influence of Graphene Oxide Concentration when Fabricating an Electrochemical Biosensor for DNA Detection.

Chiticaru EA, Pilan L, Damian CM, Vasile E, Burns JS, Ioniţă M.

Biosensors (Basel). 2019 Sep 26;9(4). pii: E113. doi: 10.3390/bios9040113.

9.

Fabrication and Biocompatibility Evaluation of Nanodiamonds-Gelatin Electrospun Materials Designed for Prospective Tissue Regeneration Applications.

Şelaru A, Drăgușin DM, Olăreț E, Serafim A, Steinmüller-Nethl D, Vasile E, Iovu H, Stancu IC, Costache M, Dinescu S.

Materials (Basel). 2019 Sep 11;12(18). pii: E2933. doi: 10.3390/ma12182933.

10.

Gastric cancer: Translating novels concepts into clinical practice.

Salati M, Orsi G, Smyth E, Aprile G, Beretta G, De Vita F, Di Bartolomeo M, Fanotto V, Lonardi S, Morano F, Pietrantonio F, Pinto C, Rimassa L, Vasile E, Vivaldi C, Zaniboni A, Ziranu P, Cascinu S.

Cancer Treat Rev. 2019 Sep;79:101889. doi: 10.1016/j.ctrv.2019.101889. Epub 2019 Aug 14. Review. Erratum in: Cancer Treat Rev. 2019 Dec;81:101932.

PMID:
31445415
11.

Enhancing Electrocatalytic Activity through Liquid-Phase Exfoliation of NiFe Layered Double Hydroxide Intercalated with Metal Phthalocyanines in the Presence of Graphene.

Morales DM, Barwe S, Vasile E, Andronescu C, Schuhmann W.

Chemphyschem. 2019 Nov 19;20(22):3030-3036. doi: 10.1002/cphc.201900577. Epub 2019 Aug 14.

12.

Early Tumor Shrinkage and Depth of Response Evaluation in Metastatic Pancreatic Cancer Treated with First Line Chemotherapy: An Observational Retrospective Cohort Study.

Vivaldi C, Fornaro L, Cappelli C, Pecora I, Catanese S, Salani F, Cacciato Insilla A, Kauffmann E, Donati F, Pasquini G, Massa V, Napoli N, Lencioni M, Boraschi P, Campani D, Boggi U, Caramella D, Falcone A, Vasile E.

Cancers (Basel). 2019 Jul 4;11(7). pii: E939. doi: 10.3390/cancers11070939.

13.

Caring for Patients With Physical Disabilities: Assessment of an Innovative Spinal Cord Injury Session That Addresses an Educational Gap.

John JT, Block L, Stein A, Vasile E, Barilla-LaBarca ML.

Am J Phys Med Rehabil. 2019 Nov;98(11):1031-1035. doi: 10.1097/PHM.0000000000001251.

PMID:
31232707
14.

Comparative analysis of honey and citrate stabilized gold nanoparticles: In vitro interaction with proteins and toxicity studies.

Boldeiu A, Simion M, Mihalache I, Radoi A, Banu M, Varasteanu P, Nadejde P, Vasile E, Acasandrei A, Popescu RC, Savu D, Kusko M.

J Photochem Photobiol B. 2019 Aug;197:111519. doi: 10.1016/j.jphotobiol.2019.111519. Epub 2019 Jun 5.

PMID:
31228688
15.

Combination Chemotherapy in Patients With Advanced Pancreatic Cancer With an Eastern Cooperative Oncology Group Performance Status of 2: Lights and Shadows of a Frail Route.

Pecora I, Fornaro L, Vasile E, Catanese S, Salani F, Vivaldi C.

J Clin Oncol. 2019 Aug 1;37(22):1978-1979. doi: 10.1200/JCO.19.00127. Epub 2019 Jun 12. No abstract available.

PMID:
31188725
16.

Patients Selection for Immunotherapy in Solid Tumors: Overcome the Naïve Vision of a Single Biomarker.

Signorelli D, Giannatempo P, Grazia G, Aiello MM, Bertolini F, Mirabile A, Buti S, Vasile E, Scotti V, Pisapia P, Cona MS, Rolfo C, Malapelle U; Immune-Oncology YOUNG Group.

Biomed Res Int. 2019 Apr 24;2019:9056417. doi: 10.1155/2019/9056417. eCollection 2019. Review.

17.

Tunable photoluminescence from interconnected graphene network with potential to enhance the efficiency of a hybrid Si nanowire solar cell.

Mihalache I, Purcarea A, Vasile E, Pachiu C, Eremia SAV, Radoi A, Kusko M.

Phys Chem Chem Phys. 2019 May 8;21(18):9564-9573. doi: 10.1039/c9cp00751b.

PMID:
31020961
18.

The Italian Rare Pancreatic Exocrine Cancer Initiative.

Brunetti O, Luchini C, Argentiero A, Tommasi S, Mangia A, Aprile G, Marchetti P, Vasile E, Casadei Gardini A, Scartozzi M, Barni S, Delfanti S, De Vita F, Di Costanzo F, Milella M, Cella CA, Berardi R, Cataldo I, Santini D, Doglioni C, Maiello E, Lawlor RT, Mazzaferro V, Lonardi S, Giuliante F, Brandi G, Scarpa A, Cascinu S, Silvestris N.

Tumori. 2019 Aug;105(4):353-358. doi: 10.1177/0300891619839461. Epub 2019 Apr 9.

PMID:
30967031
19.

Novel PEG-Modified Hybrid PLGA-Vegetable Oils Nanostructured Carriers for Improving Performances of Indomethacin Delivery.

Ghitman J, Stan R, Ghebaur A, Cecoltan S, Vasile E, Iovu H.

Polymers (Basel). 2018 May 24;10(6). pii: E579. doi: 10.3390/polym10060579.

20.

Advanced Polybenzoxazine Structures Based on Modified Reduced Graphene Oxide.

Bîru EI, Gârea SA, Nicolescu A, Vasile E, Iovu H.

Polymers (Basel). 2018 Aug 24;10(9). pii: E941. doi: 10.3390/polym10090941.

21.

Cellulose acetate/layered double hydroxide adsorptive membranes for efficient removal of pharmaceutical environmental contaminants.

Raicopol MD, Andronescu C, Voicu SI, Vasile E, Pandele AM.

Carbohydr Polym. 2019 Jun 15;214:204-212. doi: 10.1016/j.carbpol.2019.03.042. Epub 2019 Mar 14.

PMID:
30925990
22.

FOLFIRINOX Adjuvant Therapy for Pancreatic Cancer.

Vivaldi C, Fornaro L, Vasile E.

N Engl J Med. 2019 Mar 21;380(12):1187-1188. doi: 10.1056/NEJMc1900712. No abstract available.

PMID:
30893543
23.

Validated clinico-pathologic nomogram in the prediction of HER2 status in gastro-oesophageal cancer.

Fornaro L, Vivaldi C, Parnofiello A, Ugolini C, Aprile G, De Maglio G, Pecora I, Iacono D, Crivelli F, Catanese S, Cardellino GG, Lencioni M, Vasile E, Salani F, Clerico M, Calvetti L, Falcone A, Fasola G, Fontanini G, Montagnani F.

Br J Cancer. 2019 Mar;120(5):522-526. doi: 10.1038/s41416-019-0399-4. Epub 2019 Feb 12.

24.

Second-line treatment efficacy and toxicity in older vs. non-older patients with advanced gastric cancer: A multicentre real-world study.

Fanotto V, Fornaro L, Bordonaro R, Rosati G, Rimassa L, Di Donato S, Santini D, Tomasello G, Leone F, Silvestris N, Stragliotto S, Scartozzi M, Giampieri R, Nichetti F, Antonuzzo L, Cinieri S, Avallone A, Pellegrino A, Melisi D, Vasile E, Gerratana L, Aprile G.

J Geriatr Oncol. 2019 Jul;10(4):591-597. doi: 10.1016/j.jgo.2018.11.009. Epub 2018 Dec 11.

PMID:
30551958
25.

The emerging role of liquid biopsy in diagnosis, prognosis and treatment monitoring of pancreatic cancer.

Rofi E, Vivaldi C, Del Re M, Arrigoni E, Crucitta S, Funel N, Fogli S, Vasile E, Musettini G, Fornaro L, Falcone A, Danesi R.

Pharmacogenomics. 2019 Jan;20(1):49-68. doi: 10.2217/pgs-2018-0149. Epub 2018 Dec 6.

PMID:
30520336
26.

Nivolumab in never-smokers with advanced squamous non-small cell lung cancer: Results from the Italian cohort of an expanded access program.

Garassino MC, Crinò L, Catino A, Ardizzoni A, Cortesi E, Cappuzzo F, Bordi P, Calabrò L, Barbieri F, Santo A, Altavilla G, Ambrosio F, Mini E, Vasile E, Morgillo F, Scoppola A, Bengala C, Follador A, Tedde N, Giannarelli D, Lo Russo G, Vitiello F.

Tumour Biol. 2018 Nov;40(11):1010428318815047. doi: 10.1177/1010428318815047.

PMID:
30486741
27.

Plasma miR-181a-5p Downregulation Predicts Response and Improved Survival After FOLFIRINOX in Pancreatic Ductal Adenocarcinoma.

Meijer LL, Garajová I, Caparello C, Le Large TYS, Frampton AE, Vasile E, Funel N, Kazemier G, Giovannetti E.

Ann Surg. 2018 Dec 9. doi: 10.1097/SLA.0000000000003084. [Epub ahead of print]

PMID:
30394883
28.

Optical Graphene-Based Biosensor for Nucleic Acid Detection; Influence of Graphene Functionalization and Ionic Strength.

Becheru DF, Vlăsceanu GM, Banciu A, Vasile E, Ioniţă M, Burns JS.

Int J Mol Sci. 2018 Oct 19;19(10). pii: E3230. doi: 10.3390/ijms19103230.

29.

Bone metastases in biliary cancers: A multicenter retrospective survey.

Santini D, Brandi G, Aprile G, Russano M, Cereda S, Leone F, Lonardi S, Fornaro L, Scartozzi M, Silvestris N, Barni S, Pantano F, Vincenzi B, Palloni A, Frega G, Casagrande M, Ferrari L, Dadduzio V, Intini R, Filippi R, Vasile E, Vivaldi C, Faloppi L, Brunetti O, Reni M, Aglietta M, Tonini G.

J Bone Oncol. 2018 Apr 7;12:33-37. doi: 10.1016/j.jbo.2017.11.006. eCollection 2018 Sep.

30.

Locally advanced gastro-oesophageal cancer: Recent therapeutic advances and research directions.

Fornaro L, Vasile E, Aprile G, Goetze TO, Vivaldi C, Falcone A, Al-Batran SE.

Cancer Treat Rev. 2018 Sep;69:90-100. doi: 10.1016/j.ctrv.2018.06.012. Epub 2018 Jun 18. Review.

PMID:
29957366
31.

Coactivator condensation at super-enhancers links phase separation and gene control.

Sabari BR, Dall'Agnese A, Boija A, Klein IA, Coffey EL, Shrinivas K, Abraham BJ, Hannett NM, Zamudio AV, Manteiga JC, Li CH, Guo YE, Day DS, Schuijers J, Vasile E, Malik S, Hnisz D, Lee TI, Cisse II, Roeder RG, Sharp PA, Chakraborty AK, Young RA.

Science. 2018 Jul 27;361(6400). pii: eaar3958. doi: 10.1126/science.aar3958. Epub 2018 Jun 21.

32.

Systemic Chemotherapy for Advanced Rare Pancreatic Histotype Tumors: A Retrospective Multicenter Analysis.

Brunetti O, Aprile G, Marchetti P, Vasile E, Casadei Gardini A, Scartozzi M, Barni S, Delfanti S, De Vita F, Di Costanzo F, Milella M, Cella CA, Berardi R, Cataldo I, Scarpa A, Basile D, Mazzuca F, Graziano G, Argentiero A, Santini D, Reni M, Cascinu S, Silvestris N.

Pancreas. 2018 Jul;47(6):759-771. doi: 10.1097/MPA.0000000000001063.

PMID:
29771769
33.

Italian Nivolumab Expanded Access Program in Nonsquamous Non-Small Cell Lung Cancer Patients: Results in Never-Smokers and EGFR-Mutant Patients.

Garassino MC, Gelibter AJ, Grossi F, Chiari R, Soto Parra H, Cascinu S, Cognetti F, Turci D, Blasi L, Bengala C, Mini E, Baldini E, Quadrini S, Ceresoli GL, Antonelli P, Vasile E, Pinto C, Fasola G, Galetta D, Macerelli M, Giannarelli D, Lo Russo G, de Marinis F.

J Thorac Oncol. 2018 Aug;13(8):1146-1155. doi: 10.1016/j.jtho.2018.04.025. Epub 2018 May 3.

34.

PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC.

Del Re M, Marconcini R, Pasquini G, Rofi E, Vivaldi C, Bloise F, Restante G, Arrigoni E, Caparello C, Bianco MG, Crucitta S, Petrini I, Vasile E, Falcone A, Danesi R.

Br J Cancer. 2018 Mar 20;118(6):820-824. doi: 10.1038/bjc.2018.9. Epub 2018 Mar 6.

35.

A patient with MEN1 and end-stage chronic kidney disease due to Alport syndrome: Decision making on the eligibility of transplantation.

Matrone A, Brancatella A, Marchetti P, Vasile E, Boggi U, Elisei R, Cetani F, Marcocci C, Vitti P, Latrofa F.

Mol Clin Oncol. 2018 Mar;8(3):449-452. doi: 10.3892/mco.2017.1542. Epub 2017 Dec 29.

36.

Assessment and Response to Intimate Partner Violence in Home Visitation: A Qualitative Needs Assessment With Home Visitors in a Statewide Program.

Davidov DM, Coffman J, Dyer A, Bias TK, Kristjansson AL, Mann MJ, Vasile E, Abildso CG.

J Interpers Violence. 2018 Jan 1:886260518754869. doi: 10.1177/0886260518754869. [Epub ahead of print]

37.

EGFR and AKT1 overexpression are mutually exclusive and associated with a poor survival in resected gastric adenocarcinomas.

Petrini I, Lencioni M, Vasile E, Fornaro L, Belluomini L, Pasquini G, Ginocchi L, Caparello C, Musettini G, Vivaldi C, Caponi S, Ricci S, Proietti A, Fontanini G, Naccarato AG, Nardini V, Santi S, Falcone A.

Cancer Biomark. 2018 Feb 14;21(3):731-741. doi: 10.3233/CBM-170865.

PMID:
29278885
38.

Patients with NSCLC may display a low ratio of p.T790M vs. activating EGFR mutations in plasma at disease progression: implications for personalised treatment.

Del Re M, Bordi P, Petrini I, Rofi E, Mazzoni F, Belluomini L, Vasile E, Restante G, Di Costanzo F, Falcone A, Frassoldati A, van Schaik RHN, Steendam CMJ, Chella A, Tiseo M, Morganti R, Danesi R.

Oncotarget. 2017 Sep 15;8(49):86056-86065. doi: 10.18632/oncotarget.20947. eCollection 2017 Oct 17.

39.

Selecting patients for gastrectomy in metastatic esophago-gastric cancer: clinics and pathology are not enough.

Fornaro L, Fanotto V, Musettini G, Uccello M, Rimassa L, Vivaldi C, Fontanella C, Leone F, Giampieri R, Rosati G, Lencioni M, Santini D, Di Donato S, Tomasello G, Brunetti O, Pietrantonio F, Bergamo F, Scartozzi M, Avallone A, Lutrino SE, Melisi D, Antonuzzo L, Pellegrino A, Gerratana L, Cordio S, Vasile E, Aprile G.

Future Oncol. 2017 Oct;13(25):2265-2275. doi: 10.2217/fon-2017-0246. Epub 2017 Oct 4. Erratum in: Future Oncol. 2018 Mar;14 (6):577.

PMID:
28976226
40.

A retrospective analysis of patients (pts) with non-small-cell lung cancer (NSCLC) with uncommon or complex epidermal growth factor receptor (EGFR) mutations treated with tyrosine kinase inhibitors (EGFR-TKIs): clinical features and outcome.

Stasi I, Farnesi A, Vasile E, Petrini I, Luccchesi M, Lupi C, Sensi E, Giannini R, Fornaro L, Caparello C, Pasquini G, Puppo G, Finale C, Barletta M, Chella A, Allegrini G, Falcone A, Fontanini G.

Ann Oncol. 2017 Oct;28 Suppl 6:vi56. doi: 10.1093/annonc/mdx426.006. No abstract available.

41.

Analysis of DPYD and UGT1A1 genotype in patients with advanced pancreatic cancer treated with modified FOLFIRINOX.

Vivaldi C, Arrigoni E, Morganti R, Pecora I, Fidilio L, Catanese S, Restante G, Fornaro L, Crucitta S, Lencioni M, Rofi E, Vasile E, Falcone A, Danesi R, Del Re M.

Ann Oncol. 2017 Oct;28 Suppl 6:vi48. doi: 10.1093/annonc/mdx425.012. No abstract available.

42.

Early changes in plasma levels of mutant KRAS DNA as a sensitive marker of response to chemotherapy in pancreatic cancer.

Del Re M, Vivaldi C, Rofi E, Vasile E, Miccoli M, Caparello C, d'Arienzo P, Fornaro L, Falcone A, Danesi R.

Ann Oncol. 2017 Oct;28 Suppl 6:vi47. doi: 10.1093/annonc/mdx425.010. No abstract available.

43.

Biliary tract carcinoma and chronic viral hepatitis in Italy: the GICO (Gruppo Italiano COlangiocarcinoma) experience.

Filippi R, Frega G, Vivaldi C, Casadei Gardini A, Aprile G, Silvestris N, Satolli MA, Faloppi L, Santini D, Lutrino ES, Vasile E, Valgiusti M, Basile D, Brunetti O, Spadi R, Russano M, Scartozzi M, Cagnazzo C, Brandi G, Leone F.

Ann Oncol. 2017 Oct;28 Suppl 6:vi46. doi: 10.1093/annonc/mdx425.007. No abstract available.

44.

Evaluation of an Intimate Partner Violence Training for Home Visitors Using the Theory of Planned Behavior.

Abildso CG, Dyer A, Kristjansson AL, Mann MJ, Bias T, Coffman J, Vasile E, Davidov D.

Health Promot Pract. 2018 Mar;19(2):194-202. doi: 10.1177/1524839917728050. Epub 2017 Sep 11.

45.

Nanocomposite particles with improved microstructure for 3D culture systems and bone regeneration.

Cecoltan S, Stancu IC, Drăguşin DM, Serafim A, Lungu A, Ţucureanu C, Caraş I, Tofan VC, Sălăgeanu A, Vasile E, Mallet R, Chappard D, Coman C, Istodorescu M, Iovu H.

J Mater Sci Mater Med. 2017 Aug 31;28(10):153. doi: 10.1007/s10856-017-5966-8.

PMID:
28861646
46.

Poly(HydroxyButyrate-co-HydroxyValerate) (PHBHV) Nanocarriers for Silymarin Release as Adjuvant Therapy in Colo-rectal Cancer.

Radu IC, Hudita A, Zaharia C, Stanescu PO, Vasile E, Iovu H, Stan M, Ginghina O, Galateanu B, Costache M, Langguth P, Tsatsakis A, Velonia K, Negrei C.

Front Pharmacol. 2017 Aug 2;8:508. doi: 10.3389/fphar.2017.00508. eCollection 2017.

47.

Early changes in plasma DNA levels of mutant KRAS as a sensitive marker of response to chemotherapy in pancreatic cancer.

Del Re M, Vivaldi C, Rofi E, Vasile E, Miccoli M, Caparello C, d'Arienzo PD, Fornaro L, Falcone A, Danesi R.

Sci Rep. 2017 Aug 11;7(1):7931. doi: 10.1038/s41598-017-08297-z.

48.

Engineering Graphene Quantum Dots for Enhanced Ultraviolet and Visible Light p-Si Nanowire-Based Photodetector.

Mihalache I, Radoi A, Pascu R, Romanitan C, Vasile E, Kusko M.

ACS Appl Mater Interfaces. 2017 Aug 30;9(34):29234-29247. doi: 10.1021/acsami.7b07667. Epub 2017 Aug 21.

PMID:
28786288
49.

Adjuvant chemoradiotherapy (gemcitabine-based) in pancreatic adenocarcinoma: the Pisa University experience.

Sainato A, Montrone S, Pasqualetti F, Coppola M, Cernusco NLV, Panichi M, Gonnelli A, Vasile E, Morganti R, Falcone A, Boggi U, Paiar F.

Tumori. 2017 Nov 23;103(6):577-582. doi: 10.5301/tj.5000664. Epub 2017 Jul 11.

PMID:
28708229
50.

Powder Catalyst Fixation for Post-Electrolysis Structural Characterization of NiFe Layered Double Hydroxide Based Oxygen Evolution Reaction Electrocatalysts.

Andronescu C, Barwe S, Ventosa E, Masa J, Vasile E, Konkena B, Möller S, Schuhmann W.

Angew Chem Int Ed Engl. 2017 Sep 4;56(37):11258-11262. doi: 10.1002/anie.201705385. Epub 2017 Aug 11.

PMID:
28649797

Supplemental Content

Loading ...
Support Center